What are the recent trends in market size and growth for the sheep and goat pox vaccines market?
The sheep and goat pox vaccines market size has grown steadily in recent years. It will grow from $57.79 billion in 2024 to $60.58 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to increased outbreaks of sheep and goat pox, government vaccination programs, advancements in veterinary medicine, high mortality rates in livestock, increased awareness among farmers, economic losses due to disease, trade restrictions on affected areas, improved diagnostic techniques, the historical prevalence of the disease, and collaboration between veterinary institutions.
The sheep and goat pox vaccines market size is expected to see steady growth in the next few years. It will grow to $72.47 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to the growing demand for livestock products, expanding livestock farming, government subsidies for vaccines, rising investment in veterinary research, technological advancements in vaccine production, increasing awareness of animal health, international trade agreements, climate change impacting disease patterns, the emergence of new vaccine technologies, economic growth in developing regions. Major trends in the forecast period include the development of multivalent vaccines, increasing use of recombinant vaccines, growing focus on vaccine safety, rise in public-private partnerships, expansion of veterinary vaccine market, digital tracking of vaccination programs, increased funding for animal health research, regional disease eradication initiatives, growing adoption of sustainable farming practices, enhanced regulatory frameworks for vaccines.
Get Your Free Sample of The Global Sheep And Goat Pox Vaccines Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16533&type=smp
How have varous drivers impacted the growth of the sheep and goat pox vaccines market?
The growing demand for livestock products is expected to propel the growth of the sheep and goat pox vaccines market going forward. Livestock products refer to the various goods and materials derived from domesticated animals raised in agricultural settings. The increasing demand for livestock products is driven by several factors, including income and population growth, urbanization, health concerns, changing consumer preferences, globalization and trade, and economic development. Sheep and goat pox vaccines are essential for safeguarding livestock products by preventing disease outbreaks and ensuring the health and productivity of sheep and goat populations. For instance, in February 2024, according to the Department for Environment, Food, and Rural Affairs, a UK-based government department, red meat production saw an uptick, notably with mutton and lamb production showing the largest increase at 2.9%. Moreover, the total domestic fish production in 2022 amounted to 4,182 million metric tons. Therefore, the growing demand for livestock products is expected to propel the growth of the sheep and goat pox vaccines market.
What are the primary segments of the sheep and goat pox vaccines market?
The sheep and goat pox vaccines market covered in this report is segmented –
1) By Type: Live Attenuated Vaccines, Inactivated Vaccines, Other Types
2) By Route Of Administration: Injectable, Intranasal
3) By Application: Sheep, Goat
Subsegments:
1) By Live Attenuated Vaccines: Monovalent Live Attenuated Vaccines, Multivalent Live Attenuated Vaccines
2) By Inactivated Vaccines: Adjuvanted Inactivated Vaccines, Non-Adjuvanted Inactivated Vaccines
3) By Other Types: Recombinant Vaccines, DNA-Based Vaccines
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/sheep-and-goat-pox-vaccines-global-market-report
Which firms are leading the sheep and goat pox vaccines market?
Major companies operating in the sheep and goat pox vaccines market are Indian Immunologicals Ltd., Kemin Industries, Bimeda Biologicals, Hester Biosciences Limited, Dollvet, MSD Animal Health, MCI Santé Animale, Creative Biolabs, Biovex Inc., Advacare Pharma, Brilliant Bio Pharma Private Limited, Intervac (PVT) Ltd., Agrinnovate India Limited, Bio-Med Pvt Limited, JOVAC, Vetal Animal Health Products, Kenya Veterinary Vaccines Production Institute, Vedall Pharma Private Limited, Farmer’s Pharma Private Limited, Institute of Veterinary Biological Products
How will industry trends affect the trajectory of the sheep and goat pox vaccines market?
Major companies operating in the sheep and goat pox vaccine market are focusing on developing innovative products such as live attenuated vaccines to enhance immune responses while minimizing side effects. Live attenuated vaccines are vaccines that contain live viruses or bacteria that have been weakened in the lab so they can’t cause disease in healthy individuals. They stimulate a strong immune response by mimicking a natural infection without causing illness. For instance, in August 2022, the Indian Council of Agricultural Research, an India-based research institute, developed Lumpi-ProVacInd to combat Lumpy Skin Disease (LSD) in cattle. This vaccine is designed for prophylactic immunization, providing immunity for at least one year with a single dose containing 103.5 TCID50 of the attenuated LSD virus. It is safe for animals, induces a robust immune response, and must be stored at 4°C, requiring careful handling during transportation and use
Which geographic trends are shaping the sheep and goat pox vaccines market, and which region has the highest market share?
North America was the largest region in the sheep and goat pox vaccines market in 2024. The regions covered in the sheep and goat pox vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Sheep And Goat Pox Vaccines Market Report 2025 Offer?
The sheep and goat pox vaccines market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Sheep and goat pox vaccines refer to vaccines developed to prevent diseases caused by the sheep pox and goat pox viruses, which belong to the Capripoxvirus genus. These vaccines are crucial for the prevention and control of outbreaks in sheep and goat populations, as both diseases can cause significant economic losses due to high mortality rates and decreased productivity. The vaccines work by stimulating the immune system to produce antibodies against the viruses, providing protection against infection.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16533
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
